TGA approves new treatment for aggressive form of prostate cancer

Cassandra Morgan
Updated May 5 2021 - 10:04am, first published 10:02am
Canberra region resident Paul Bain, who was diagnosed with prostate cancer in 2020. Picture: Dion Georgopoulos
Canberra region resident Paul Bain, who was diagnosed with prostate cancer in 2020. Picture: Dion Georgopoulos

The Therapeutic Goods Administration has registered a new medication to treat a particularly aggressive and advanced type of prostate cancer.

Cassandra Morgan

Cassandra Morgan

Canberra Times health reporter

It has never been more important for Canberrans to be able to access reliable and accurate information about health. As The Canberra Times’ health reporter, I am committed to ensuring our readers have access to this. I, like many in the territory, have family members who work in the sector. Although providing comprehensive coverage on the coronavirus pandemic is obviously my number one priority, I aim to frequently shed light on the fantastic work our frontline professionals do, as well as the challenges they face. Email me tips and story ideas at: c.morgan@canberratimes.com.au.

Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.